New Data Points To Long Lasting Beneficial Effects Of CEL-SCI's Rheumatoid Arthritis Vaccine

Main Category: Arthritis / Rheumatology Also Included In: Immune System / Vaccines ; Clinical Trials / Drug Trials ; Conferences Article Date: 15 Nov 2008 - 0:00 PST CEL-SCI Corporation announced the ...

CEL-SCI's Rheumatoid Arthritis Vaccine Benefits Last Long

SCI Corporation presented new rheumatoid arthritis data at the 6th annual GTCbio Vaccine Conference in Vienna, Va.

Cancer foundation gives grants, awards; Brick woman among recipients

November 1, 2008 marked the Nineteenth Annual Fall Gala for the Fifth District AHEPA Cancer Research Foundation, Inc.

Keryx Biopharmaceuticals' KRX-0401 (Perifosine) Data Selected for...

Keryx Biopharmaceuticals, Inc. today announced that data from its Phase 1/2 clinical trial of KRX-0401 has been selected for oral presentation at the upcoming 50th Annual Meeting of the American Society of ...

Animal health firm will move HQ to St. Joe

The KC Animal Health Corridor initiative said Friday that its recruiting effort has helped lasso another corporate headquarters for the corridor.

Effect of coping on endocrinoimmune functions in different stress situations

Thirty-eight medical students were enrolled in this study. Cell-mediated immune function was measured using the lymphocyte proliferative response to phytohemagglutinin and interleukin-2 production during the ...

SuppreMol Announces Expansion of its Management Team and Board Changes

MARTINSRIED/MUNICH, Germany, Oct. 21, 2008 -- SuppreMol GmbH, a privately held biopharmaceutical company developing novel therapeutics for the treatment of autoimmune diseases, today announced the expansion of ...

International Space Station On-Orbit Status Report

ISS Expedition 17 Crew: Commander Sergei Volkov, Flight Engineer Oleg Kononenko, Flight Engineer Gregory Chamitoff Launch Vehicle: Soyuz TMA-12 Launch: April 8, 2008, 11:16 UT Docking: April 10, 2008 Expected ...

Nasa Iss On-Orbit Status 18 October 2008

STATUS REPORT Date Released: Saturday, October 18, 2008 Source: NASA HQ - Comments All ISS systems continue to function nominally, except those noted previously or below.

ImmunoCellular Therapeutics Announces Filing Of Patent Application...

Main Category: Cancer / Oncology Also Included In: Immune System / Vaccines ; Stem Cell Research Article Date: 12 Oct 2008 - 0:00 PDT ImmunoCellular Therapeutics, Ltd.